China Pharma Holdings Inc (CPHI) — Capital Reinvestment Ratio

Latest as of June 2025: 0.03x

China Pharma Holdings Inc (CPHI) has a Capital Reinvestment Ratio of 0.03x as of June 2025, meaning it reinvests 0% of its operating cash flow ($291.08K) in capital expenditures ($9.92K). See CPHI net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.03x
Capex / Operating Cash Flow

Operating Cash Flow

$291.08K
USD

Capital Expenditures

$9.92K
USD

Data as of

Jun 2025
Most recent filing

China Pharma Holdings Inc Capital Reinvestment Ratio (2007–2019)

This chart tracks China Pharma Holdings Inc's Capital Reinvestment Ratio across 13 annual periods. Check CPHI total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for China Pharma Holdings Inc (2007–2019)

Year-by-year Capital Reinvestment Ratio for China Pharma Holdings Inc from 2007 to 2019. For live market cap and broader valuation context, see CPHI stock market capitalisation.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2019 0.22x $608.31K $136.00K ▲ +449.5%
2018 0.04x $1.26 Million $51.15K ▼ -74.9%
2017 0.16x $841.22K $136.48K ▲ +142.9%
2016 0.07x $2.90 Million $193.40K ▼ -90.4%
2015 0.69x $3.35 Million $2.32 Million ▼ -45.8%
2014 1.28x $4.57 Million $5.84 Million ▼ -42.5%
2013 2.22x $8.60 Million $19.09 Million ▲ +62.3%
2012 1.37x $3.64 Million $4.99 Million ▲ +29.3%
2011 1.06x $5.24 Million $5.54 Million ▼ -21.7%
2010 1.35x $7.79 Million $10.52 Million ▼ -6.2%
2009 1.44x $10.67 Million $15.36 Million ▲ +10.9%
2008 1.30x $6.54 Million $8.49 Million ▲ +21.7%
2007 1.07x $2.80 Million $2.99 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow